Page last updated: 2024-09-03

vv-hemorphin-7 and Cardiometabolic Syndrome

vv-hemorphin-7 has been researched along with Cardiometabolic Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bégu-Le Corroller, A; Feron, D; Fruitier-Arnaudin, I; Mancini, J; Maraninchi, M; Nogueira, JP; Piot, JM; Valéro, R; Vialettes, B	1

Other Studies

1 other study(ies) available for vv-hemorphin-7 and Cardiometabolic Syndrome

Article	Year
Serum hemorphin-7 levels are decreased in obesity. Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:2 Topics: Adult; Blood Pressure; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Hypertension; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Peptide Fragments; Renin-Angiotensin System; Risk Factors	2013

Article

Year

Serum hemorphin-7 levels are decreased in obesity.

Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:2

Topics: Adult; Blood Pressure; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; Hemoglobins; Humans; Hypertension; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Peptide Fragments; Renin-Angiotensin System; Risk Factors

2013